Availability
Please contact us to check the availability
Specificity
-
Species reactivity
-
Product presentation
AGEs-BSA in PBS pH 7.4
Product category
Control Peptide
Antibody's raised in
-
Antibody's isotype
Antigen
Antibody's clone
-
Product is supplied as
liquid concentrate
Recommended concentration for use
1 ng/ml - 1 µg/ml
Protein concentration
1 mg/ml
Positive control
-
Pretreatment
-
Tested applications
ELISA, IHC, WB
Recommended secondary reagent
none
Storage method
Store at -20°C
UniProt number
Go to UniProt/SwissProt
Litterature
1. Takeuchi M. , Makita Z., Bucala R., Suzuki T., Koike T., and Kameda Y. (2000) Immunological evidence that non-carboxymethyllysine Advanced Glycation End-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol. Med. 6; 114-125. 2. Takeuchi M., Yanase Y., Matsuura N., Yamagishi S., Kameda Y., Bucala R., and Z. Matika (2001) Immunological detection of a novel Advanced Glycation End-Product. Mol. Med. 7; 783-791.
Tips
*Gentaur reagents are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals.
Tissue
control
Description
Antigens are peptides or recombinant or native dependent on the production method.Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.